853 related articles for article (PubMed ID: 25761609)
1. International Union of Basic and Clinical Pharmacology. XCV. Recent advances in the understanding of the pharmacology and biological roles of relaxin family peptide receptors 1-4, the receptors for relaxin family peptides.
Halls ML; Bathgate RA; Sutton SW; Dschietzig TB; Summers RJ
Pharmacol Rev; 2015; 67(2):389-440. PubMed ID: 25761609
[TBL] [Abstract][Full Text] [Related]
2. Relaxin family peptide receptors--former orphans reunite with their parent ligands to activate multiple signalling pathways.
Halls ML; van der Westhuizen ET; Bathgate RA; Summers RJ
Br J Pharmacol; 2007 Mar; 150(6):677-91. PubMed ID: 17293890
[TBL] [Abstract][Full Text] [Related]
3. Relaxin family peptides and their receptors.
Bathgate RA; Halls ML; van der Westhuizen ET; Callander GE; Kocan M; Summers RJ
Physiol Rev; 2013 Jan; 93(1):405-80. PubMed ID: 23303914
[TBL] [Abstract][Full Text] [Related]
4. Receptors for relaxin family peptides.
Bathgate RA; Ivell R; Sanborn BM; Sherwood OD; Summers RJ
Ann N Y Acad Sci; 2005 May; 1041():61-76. PubMed ID: 15956688
[TBL] [Abstract][Full Text] [Related]
5. International Union of Pharmacology LVII: recommendations for the nomenclature of receptors for relaxin family peptides.
Bathgate RA; Ivell R; Sanborn BM; Sherwood OD; Summers RJ
Pharmacol Rev; 2006 Mar; 58(1):7-31. PubMed ID: 16507880
[TBL] [Abstract][Full Text] [Related]
6. The actions of relaxin family peptides on signal transduction pathways activated by the relaxin family peptide receptor RXFP4.
Ang SY; Hutchinson DS; Evans BA; Hossain MA; Patil N; Bathgate RA; Kocan M; Summers RJ
Naunyn Schmiedebergs Arch Pharmacol; 2017 Jan; 390(1):105-111. PubMed ID: 27888281
[TBL] [Abstract][Full Text] [Related]
7. The different ligand-binding modes of relaxin family peptide receptors RXFP1 and RXFP2.
Scott DJ; Rosengren KJ; Bathgate RA
Mol Endocrinol; 2012 Nov; 26(11):1896-906. PubMed ID: 22973049
[TBL] [Abstract][Full Text] [Related]
8. Identification of the domains in RXFP4 (GPCR142) responsible for the high affinity binding and agonistic activity of INSL5 at RXFP4 compared to RXFP3 (GPCR135).
Zhu J; Kuei C; Sutton S; Kamme F; Yu J; Bonaventure P; Atack J; Lovenberg TW; Liu C
Eur J Pharmacol; 2008 Aug; 590(1-3):43-52. PubMed ID: 18582868
[TBL] [Abstract][Full Text] [Related]
9. Membrane receptors: structure and function of the relaxin family peptide receptors.
Kong RC; Shilling PJ; Lobb DK; Gooley PR; Bathgate RA
Mol Cell Endocrinol; 2010 May; 320(1-2):1-15. PubMed ID: 20138959
[TBL] [Abstract][Full Text] [Related]
10. International Union of Basic and Clinical Pharmacology. XCIV. Adhesion G protein-coupled receptors.
Hamann J; Aust G; Araç D; Engel FB; Formstone C; Fredriksson R; Hall RA; Harty BL; Kirchhoff C; Knapp B; Krishnan A; Liebscher I; Lin HH; Martinelli DC; Monk KR; Peeters MC; Piao X; Prömel S; Schöneberg T; Schwartz TW; Singer K; Stacey M; Ushkaryov YA; Vallon M; Wolfrum U; Wright MW; Xu L; Langenhan T; Schiöth HB
Pharmacol Rev; 2015; 67(2):338-67. PubMed ID: 25713288
[TBL] [Abstract][Full Text] [Related]
11. Mechanism for insulin-like peptide 5 distinguishing the homologous relaxin family peptide receptor 3 and 4.
Hu MJ; Shao XX; Wang JH; Wei D; Guo YQ; Liu YL; Xu ZG; Guo ZY
Sci Rep; 2016 Jul; 6():29648. PubMed ID: 27404393
[TBL] [Abstract][Full Text] [Related]
12. Discovery of a small molecule RXFP3/4 agonist that increases food intake in rats upon acute central administration.
DeChristopher B; Park SH; Vong L; Bamford D; Cho HH; Duvadie R; Fedolak A; Hogan C; Honda T; Pandey P; Rozhitskaya O; Su L; Tomlinson E; Wallace I
Bioorg Med Chem Lett; 2019 Apr; 29(8):991-994. PubMed ID: 30824200
[TBL] [Abstract][Full Text] [Related]
13. The relaxin family peptide receptors and their ligands: new developments and paradigms in the evolution from jawless fish to mammals.
Yegorov S; Bogerd J; Good SV
Gen Comp Endocrinol; 2014 Dec; 209():93-105. PubMed ID: 25079565
[TBL] [Abstract][Full Text] [Related]
14. Signal transduction pathways activated by insulin-like peptide 5 at the relaxin family peptide RXFP4 receptor.
Ang SY; Hutchinson DS; Patil N; Evans BA; Bathgate RAD; Halls ML; Hossain MA; Summers RJ; Kocan M
Br J Pharmacol; 2017 May; 174(10):1077-1089. PubMed ID: 27243554
[TBL] [Abstract][Full Text] [Related]
15. International Union of Basic and Clinical Pharmacology. XCIII. The parathyroid hormone receptors--family B G protein-coupled receptors.
Gardella TJ; Vilardaga JP
Pharmacol Rev; 2015; 67(2):310-37. PubMed ID: 25713287
[TBL] [Abstract][Full Text] [Related]
16. Development of a selective agonist for relaxin family peptide receptor 3.
Wei D; Hu MJ; Shao XX; Wang JH; Nie WH; Liu YL; Xu ZG; Guo ZY
Sci Rep; 2017 Jun; 7(1):3230. PubMed ID: 28607363
[TBL] [Abstract][Full Text] [Related]
17. Real-time examination of cAMP activity at relaxin family peptide receptors using a BRET-based biosensor.
Valkovic AL; Leckey MB; Whitehead AR; Hossain MA; Inoue A; Kocan M; Bathgate RAD
Pharmacol Res Perspect; 2018 Oct; 6(5):e00432. PubMed ID: 30263124
[TBL] [Abstract][Full Text] [Related]
18. Exploring receptor selectivity of the chimeric relaxin family peptide R3/I5 by incorporating unnatural amino acids.
Wang JH; Hu MJ; Zhang L; Shao XX; Lv CH; Liu YL; Xu ZG; Guo ZY
Biochimie; 2018 Nov; 154():77-85. PubMed ID: 30102931
[TBL] [Abstract][Full Text] [Related]
19. Identification of important residues of insulin-like peptide 5 and its receptor RXFP4 for ligand-receptor interactions.
Wang XY; Guo YQ; Shao XX; Liu YL; Xu ZG; Guo ZY
Arch Biochem Biophys; 2014 Sep; 558():127-32. PubMed ID: 25043977
[TBL] [Abstract][Full Text] [Related]
20. Orthosteric, Allosteric and Biased Signalling at the Relaxin-3 Receptor RXFP3.
Kocan M; Ang SY; Summers RJ
Neurochem Res; 2016 Mar; 41(3):610-9. PubMed ID: 26294284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
